Abstract
Many lines of evidence link antimicrobial-resistant human infections to foodborne pathogens of animal origin. Types of evidence reviewed include: (1) direct epidemiologic studies; (2) temporal evidence; (3) additional circumstantial evidence; (4) trends in antimicrobial resistance among Salmonella isolates; and (5) trends in antimicrobial resistance among other pathogens, such as Campylobacter jejuni. Commensal microorganisms in animals and humans may contribute to antimicrobial resistance among pathogens that cause disease among humans. For instance, enterococci of food-animal origin, particularly strains that are vancomycin resistant, have been linked to strains found in the human gastrointestinal tract. The latent period between the introduction of a given antimicrobial and emergence of resistance varies considerably, but once the prevalence in a population reaches a certain level, control becomes extremely difficult.
Generated Summary
This research article explores the link between antimicrobial resistance in human infections and foodborne pathogens originating from animals. The study examines various types of evidence, including direct epidemiological studies, temporal patterns, circumstantial evidence, and trends in antimicrobial resistance among different pathogens such as *Salmonella* and *Campylobacter jejuni*. The study underscores the role of commensal microorganisms in animals and humans in contributing to antimicrobial resistance in human pathogens. The introduction discusses the significant impact of foodborne pathogens of animal origin on human health, with particular emphasis on invasive intestinal bacterial pathogens such as *Campylobacter, Salmonella, Listeria, Escherichia coli* O157, *Yersinia*, and *Vibrio*. The article highlights the challenges in controlling the spread of antimicrobial resistance once it reaches a certain prevalence in a population, and the complex interplay between antimicrobial use in food animals and the emergence of resistance in pathogens that cause human diseases.
Key Findings & Statistics
- In 1999, there were 4533 culture-confirmed *Salmonella* infections (17.7 per 100,000 population) and 3794 *Campylobacter* infections (14.8 per 100,000 population) in the 8 FoodNet surveillance states (26.9 million population).
- The rate of *Campylobacter* infections decreased by 26% between 1996 and 1999.
- The rate of *E. coli* O157 infections decreased by 22% between 1996 and 1999.
- Hospitalization rates: *Listeria* infections (88%), *Yersinia* (36%), *E. coli* O157 (37%), *Salmonella* (22%).
- In 1999, *Salmonella* Typhimurium showed even higher frequencies of resistance to ampicillin (41% of isolates), chloramphenicol (29%), streptomycin (43%), sulfamethoxazole (45%), and tetracycline (42%).
- In 1999, human *Salmonella* strains resistant to 8 or more antimicrobials increased in frequency from 0.3% of all non-Typhi isolates in 1996 to 2% in 1999.
- *Salmonella* Newport increased from 1.3% in 1998 to 17.2% in 1999.
- The prevalence of quinolone resistance among *Campylobacter* strains isolated between 1982 and 1989 from poultry products increased from 0% to 14%, whereas the prevalence in humans increased from 0% to 11% in the Netherlands.
- 70% of all antimicrobial agents used in the United States (24.5 million pounds per year) are administered to livestock for nontherapeutic purposes.
- The human disease burden with salmonellosis is considerable, estimated at 1,400,000 *Salmonella* infections annually in the United States and causing 16,000 hospitalizations and nearly 600 deaths.
- In 1998 FoodNet study, 11% of 858 human isolates tested nationwide were ciprofloxacin resistant.
Other Important Findings
- The article highlights that antimicrobial resistance can be transferred to pathogens that cause disease in humans.
- The article emphasizes the role of antimicrobial use in food animals in driving resistance among pathogens.
- The article discusses that *Salmonella* serotypes differ in their ability to infect the human intestinal tract and cause disease.
- The use of fluoroquinolones in poultry has been linked to the emergence of resistance in *Campylobacter jejuni*.
- Avoparcin use was banned in Denmark in 1995, in Germany in 1996, and in all European Union states in 1997.
- Since 1991, *Salmonella* species resistant to expanded spectrum cephalosporins have been noted in South America, Europe, North Africa, and the Middle East, and this resistance may be spreading to the United States.
- The article discusses the case of a child in 2000 with ceftriaxone-resistant Salmonella infection, linked to cattle.
Limitations Noted in the Document
- The document acknowledges that the data available may not always be adequate to directly establish a definite hazard to human health.
- The study notes the difficulties in performing “trace-back” studies due to the mass production and transport of livestock, as well as time lags in identifying antimicrobial-resistant infections in humans.
- The study notes that the model used to predict serotype distribution of Salmonella isolates among humans has limitations, as it assumes an equal probability of causing illness for all Salmonella serotypes.
- The absence of antimicrobial resistance does not provide assurance that it will not become a problem, and once resistance reaches high prevalence levels, it is difficult to reduce.
Conclusion
The central theme of the article is the link between antimicrobial resistance in foodborne pathogens of animal origin and human health. The article provides a critical overview of the evidence, including epidemiological studies, temporal patterns, and circumstantial evidence, linking the use of antimicrobials in food animals to the emergence and spread of resistance in human pathogens. The article highlights the role of *Salmonella* and *Campylobacter jejuni* as key foodborne pathogens and their increasing resistance to various antimicrobials. The article discusses that the health impact of these foodborne infections becomes ever more serious because of the growing rate of antimicrobial resistance among these foodborne pathogens, a problem that has been recognized for 3 decades. The article emphasizes that the increasing prevalence of antimicrobial resistance among foodborne pathogens poses a serious threat to public health and food safety. It also suggests that the overuse of antimicrobials in food animals may enhance the development of antimicrobial resistance and its transfer to pathogens that cause disease in humans. The article emphasizes the need for integrated national databases to support science-driven policies for approving antimicrobials for use in food animals. The article also concludes that once antimicrobial resistance reaches high prevalence, it becomes extremely difficult to reverse, highlighting the importance of proactive measures to mitigate the risks associated with antimicrobial use in food production. The final thought is that monitoring programs can be helpful in recognizing the spread of resistance while there is still time to control it.